Reference : Determination of Meprobamate in Pharmaceutical Dosage Forms Also Containing Carbromal by...
Scientific journals : Article
Human health sciences : Pharmacy, pharmacology & toxicology
http://hdl.handle.net/2268/7422
Determination of Meprobamate in Pharmaceutical Dosage Forms Also Containing Carbromal by Liquid Chromatography and Indirect Photometric Detection
English
Bechet, I. [> > > >]
Ceccato, Attilio mailto [Université de Liège - ULg > Département de pharmacie > Analyse des médicaments >]
Hubert, Philippe mailto [Université de Liège - ULg > > Chimie analytique >]
Herné, Patrick mailto [Université de Liège - ULg > Département de pharmacie > Déontologie et législation pharmaceutiques >]
Crommen, Jacques mailto [Université de Liège - ULg > Département de pharmacie > Analyse des médicaments >]
1992
Journal of Pharmaceutical & Biomedical Analysis
10
10-12, Oct-Dec
995-9
International
0731-7085
[en] In a pharmaceutical form also containing carbromal, meprobamate could not be quantified selectively by classical methods described in pharmacopoeias due to a significant interference from carbromal. Consequently, reversed-phase HPLC methods have been developed to separate the two active ingredients using indirect photometric detection to visualize and determine meprobamate which has very poor chromophoric properties. Different parameters influencing the sensitivity of the indirect response, such as the nature of the highly absorbing compound added to the mobile phase (the marker) as well as the methanol content and the pH of this phase, have been studied. Two chromatographic systems containing benzoic acid or cinnamic acid as the marker, have been optimized and validated. Good linearity and reproducibility have been obtained with both systems but the cinnamic acid method has the advantage that meprobamate and carbromal can be determined simultaneously at 273 nm.
http://hdl.handle.net/2268/7422

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Hubert_1992_J-Pharma_Biomed-Anal_995.pdfPublisher postprint356.57 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.